Acyclovir Recall: Fresenius Kabi Compounding Lot C274-000049124
Announced 2026-02-18 · FDA
The recall covers 1,057 single-use intravenous bags of acyclovir sodium 200 mg in 0.9% Sodium Chloride Injection, USP, distributed nationwide in the United States. The reason is lack of assurance of sterility. Recall Lot # C274-000049124 with expiration date 28-Feb-26.
| Brand | Fresenius Kabi Compounding, LLC |
|---|---|
| Product | acyclovir sodium, 200 mg, 200mg added to 100 mL, 0.9% Sodium Chloride Injection, USP, For Intravenous Use, Single-Use Bag, Fagron Sterile Services, 20 Dan Road, Canton, MA 02021, NDC 71506-035-56 |
| Reason | Lack of Assurance of Sterility |
| Severity | moderate |
| Units affected | 10548 |
| Distribution | US Nationwide. |
| Agency | FDA |
| Recall / campaign no. | Lot # C274-000049124, Exp Date: 28-Feb-26. |
WHAT YOU SHOULD DO
- Do not use any acyclovir sodium IV bags with Lot C274-000049124.
- If you have affected product, contact your hospital pharmacist or supplier for return or replacement instructions.
- If you have used an affected bag or have concerns, contact your healthcare provider.
- Report adverse events to your healthcare provider or FDA MedWatch.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.